Stem cells banish severe autoimmune disease for 15 years

A groundbreaking stem cell therapy has achieved a remarkable 15-year remission for two patients suffering from a severe autoimmune disease that attacks the spinal cord and optic nerve. This pioneering treatment, detailed in a publication on June 19, 2026, marks a significant milestone in managing conditions previously considered chronic and debilitating. The therapy involves extracting a patient's own stem cells, reprogramming them into a specific type of immune cell, and then reinfusing them. This process effectively 'resets' the immune system, preventing it from attacking the body's own tissues. The two initial recipients of this treatment were diagnosed with neuromyelitis optica spectrum disorder (NMOSD), a condition characterized by inflammation and damage to the central nervous system. Prior to this therapy, NMOSD management often involved immunosuppressive drugs with significant side effects and limited long-term efficacy. The sustained remission observed over 15 years suggests a potentially curative approach for NMOSD and offers hope for developing similar treatments for other autoimmune disorders. Researchers are now focused on understanding the precise mechanisms behind this long-term remission and exploring the therapy's applicability to a wider range of autoimmune conditions, aiming to provide lasting relief and improve the quality of life for countless individuals.